Safety assessment for ibuprofen using disproportionality analysis: a decade of data from the Romanian national pharmacovigilance system
Cristina Anamaria Buciuman, Anca Butuca, Adina Frum, Felicia Gabriela Gligor, Mariana Ganea, Laura Grațiela Vicaş, Eleonora Marian, Octavia Gligor, Carmen Maximiliana Dobrea, Corina Florentina Moisa, Annamaria Pallag, Tunde Jurca, Claudiu Morgovan · 2026
Read Safety assessment for ibuprofen using disproportionality analysis: a decade of data from the Romanian national pharmacovigilance system by Cristina Anamaria Buciuman, Anca Butuca, Adina Frum, Felicia Gabriela Gligor, Mariana Ganea, Laura Grațiela Vicaş, Eleonora Marian, Octavia Gligor, Carmen Maximiliana Dobrea, Corina Florentina Moisa, Annamaria Pallag, Tunde Jurca, Claudiu Morgovan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13506849.txt.
Description
IntroductionThe aim of this study was to evaluate the adverse reactions associated with ibuprofen, one of the most widely used analgesic-antipyretic agents, in comparison with other nonsteroidal anti-inflammatory drugs (NSAIDs). In Romania, most pharmaceutical forms of ibuprofen are available over the counter, except for parenteral formulations and high-dose oral forms (800 mg), which require a prescription.
Catalog record
| CREATOR | Cristina Anamaria Buciuman, Anca Butuca, Adina Frum, Felicia Gabriela Gligor, Mariana Ganea, Laura Grațiela Vicaş, Eleonora Marian, Octavia Gligor, Carmen Maximiliana Dobrea, Corina Florentina Moisa, Annamaria Pallag, Tunde Jurca, Claudiu Morgovan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |